VRTX - 2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
This year has been one of losses for many top stocks. Higher inflation and a generally pessimistic market sentiment have weighed on market performance across industries. But some companies have managed to defy this negative trend -- and beat the bear market.
Two biotech companies are great examples of this: giant Vertex Pharmaceuticals (NASDAQ: VRTX) and up-and-coming player Axsome Therapeutics (NASDAQ: AXSM) . Both stocks soared in the double digits this year. And this movement isn't over.
Vertex shares have climbed about 40% so far this year. And there's a a compelling argument to be made that this movement should continue. Vertex may be about to show that it can expand beyond its specialty of cystic fibrosis (CF) treatment -- and with a potential blockbuster product.
For further details see:
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond